Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour, Residual”

768 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 768 results

Not applicableActive Not RecruitingNCT05029869
What this trial is testing

Monitoring Minimal Residual Disease in Gastric Cancer by Liquid Biopsy Study Description

Who this might be right for
Gastric CancerctDNA
University Medical Center Ho Chi Minh City (UMC) 100
Not applicableLooking for participantsNCT06697483
What this trial is testing

Risk Stratification and MRD-driven Maintenance for MM After ASCT

Who this might be right for
Multiple Myeloma
Peking University People's Hospital 100
Not applicableUnknownNCT04362462
What this trial is testing

Molecular Profiling After Neoadjuvant Chemotherapy for Triple-negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Texas Tech University Health Sciences Center, El Paso 120
Large-scale testing (Phase 3)Looking for participantsNCT05633654
What this trial is testing

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Who this might be right for
Triple Negative Breast Cancer
Gilead Sciences 1,514
Not applicableNot Yet RecruitingNCT07413146
What this trial is testing

Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial

Who this might be right for
Minimal Residual DiseaseImmunoscoreNeoadjuvant Chemotherapy+1 more
Sun Yat-sen University 100
Large-scale testing (Phase 3)Study completedNCT01864746
What this trial is testing

Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery

Who this might be right for
Breast CancerHormonreceptor PositiveHer2-normal+2 more
GBG Forschungs GmbH 1,250
Testing effectiveness (Phase 2)Study completedNCT02567253
What this trial is testing

Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cancer
University Hospital, Ghent 56
Testing effectiveness (Phase 2)Study completedNCT02789254
What this trial is testing

FLYSYN in MRD Positive AML

Who this might be right for
Acute Myeloid Leukemia
Synimmune GmbH 31
Not applicableLooking for participantsNCT06963307
What this trial is testing

Novel Epigenetic Mapping in Cell-Free DNA for the Detection of Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
JaxBio Ltd 300
Not applicableActive Not RecruitingNCT02633111
What this trial is testing

DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas

Who this might be right for
B-cell Non-Hodgkin LymphomaAggressive
Memorial Sloan Kettering Cancer Center 501
Testing effectiveness (Phase 2)Looking for participantsNCT06992336
What this trial is testing

Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 411
Testing effectiveness (Phase 2)Active Not RecruitingNCT03756298
What this trial is testing

Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
National Cancer Center, Korea 284
Not applicableStudy completedNCT02230410
What this trial is testing

Cryo Balloon for Residual Barrett's Esophagus

Who this might be right for
Barrett's Esophagus
Mayo Clinic 18
Large-scale testing (Phase 3)Looking for participantsNCT03793517
What this trial is testing

Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT

Who this might be right for
Stem Cell Transplant ComplicationsLeukemia, Myeloid, AcuteLeukemia Relapse
Peking University People's Hospital 55
Not applicableLooking for participantsNCT05959720
What this trial is testing

Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil

Who this might be right for
Acute Lymphoid LeukemiaMinimal Residual DiseaseGene Abnormality+1 more
Instituto do Cancer do Estado de São Paulo 180
Very early researchNot Yet RecruitingNCT06979661
What this trial is testing

Trial of ctDNA of Guidance to Determine PostOperative Radiation Therapy

Who this might be right for
Lung CancerNon Small Cell Lung CancerLung Cancer Recurrent
Rutgers, The State University of New Jersey 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT03863184
What this trial is testing

Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL

Who this might be right for
Mantle Cell Lymphoma
Weill Medical College of Cornell University 37
Early research (Phase 1)Looking for participantsNCT05535855
What this trial is testing

UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1

Who this might be right for
Acute Lymphoid LeukemiaAcute Lymphoblastic Leukemia
University of Colorado, Denver 29
Testing effectiveness (Phase 2)Ended earlyNCT01158885
What this trial is testing

Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia

Who this might be right for
Minimal Residual DiseaseLeukemia, Lymphoblastic, AcuteLeukemia, Myelogenous, Acute
Therapeutic Advances in Childhood Leukemia Consortium 2
Testing effectiveness (Phase 2)Study completedNCT01931163
What this trial is testing

NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Jenny C. Chang, MD 24
Load More Results